These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33214078)

  • 1. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
    Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer ≤1 cm or >1-2 cm: a population-based study.
    Liang Z; Wang X; Yang H; Fu H; Li M; Feng Z; Peng Z; Wang H
    Future Oncol; 2020 Jan; 16(3):4497-4509. PubMed ID: 31845824
    [No Abstract]   [Full Text] [Related]  

  • 3. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Lobectomy versus Sub-Lobar Resection on the Survival in Adults with Stage IA Left Upper Lobe Non-Small Cell Lung Cancer: A Retrospective Cohort Study Based on the Surveillance, Epidemiology, and End Results Database.
    Wen H; Liang C
    Oncology; 2024; 102(6):525-532. PubMed ID: 37812916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non-small-cell lung cancer: A propensity-match analysis.
    Wald O; Sadeh BM; Bdolah-Abram T; Erez E; Shapira OM; Izhar U
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1339. PubMed ID: 33570255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
    Liang W; He J; Shen Y; Shen J; He Q; Zhang J; Jiang G; Wang Q; Liu L; Gao S; Liu D; Wang Z; Zhu Z; Ng CS; Liu CC; Petersen RH; Rocco G; D'Amico T; Brunelli A; Chen H; Zhi X; Liu B; Yang Y; Chen W; Zhou Q; He J
    J Clin Oncol; 2017 Apr; 35(11):1162-1170. PubMed ID: 28029318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Altorki NK; Sedrakyan A
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):858-866. PubMed ID: 31168591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublobar resection is associated with decreased survival for patients with early stage large-cell neuroendocrine carcinoma of the lung.
    Lutfi W; Schuchert MJ; Dhupar R; Sarkaria I; Christie NA; Yang CJ; Deng JZ; Luketich JD; Okusanya OT
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):517-524. PubMed ID: 31177277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
    Ding H; Wang H; Xu L; Song N; Jiang G
    Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Sedrakyan A; Altorki NK
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2454-2465.e1. PubMed ID: 30954298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
    Stiles BM; Kamel MK; Nasar A; Harrison S; Nguyen AB; Lee P; Port JL; Altorki NK
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):511-517. PubMed ID: 28007869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis.
    Razi SS; John MM; Sainathan S; Stavropoulos C
    J Surg Res; 2016 Feb; 200(2):683-9. PubMed ID: 26490227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of examined lymph node count in older patients with stage T1N0M0 pulmonary carcinoid tumours: a population-based propensity score-matched analysis.
    Yang H; Fang Z; Liu T; Zhu X; Luo L
    Aging Clin Exp Res; 2023 Jan; 35(1):203-212. PubMed ID: 36319940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.
    Lin X; Yao J; Huang B; Chen T; Xie L; Huang R
    Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study.
    Rodriguez-Quintero JH; Kamel MK; Jindani R; Vimolratana M; Chudgar NP; Stiles BM
    Eur J Cardiothorac Surg; 2024 Jan; 65(1):. PubMed ID: 38147358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of examined lymph node count on survival outcomes in patients with stage T1-2N0M0 small cell lung cancer undergoing surgery: A retrospective cohort study.
    Wan XB; Liang HW; Liu Y; Huang W; Pan XB
    Medicine (Baltimore); 2024 May; 103(22):e38381. PubMed ID: 39259081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.